Rhenman & Partners Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
|
|||||
|
2025
Q3 | $3.59M | Buy |
|
|||||
|
2025
Q2 | $3.39M | Buy |
|
|||||
|
2025
Q1 | $2.97M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $5.05M | Hold |
|
|||||
|
2020
Q2 | $4.81M | Sell |
|
|||||
|
2020
Q1 | $3.04M | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $4.41M | Sell |
|
|||||
|
2017
Q3 | $5.33M | Buy |
|
|||||
|
2017
Q2 | $2.21M | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $489K | Sell |
|
|||||
|
2016
Q1 | $2.53M | Buy |
|